Advanced search
Start date
Betweenand

Gisele Picolo

CV Lattes ResearcherID ORCID


Secretaria da Saúde (São Paulo - Estado). Instituto Butantan  (Institutional affiliation for the last research proposal)
Birthplace: Brazil

graduate at Biologia from Universidade Presbiteriana Mackenzie (1996), master's at Veterinary Medicine from Universidade de São Paulo (1999) and ph.d. at Pharmacology from Universidade de São Paulo (2003). Has experience in Pharmacology, focusing on General Pharmacology, acting on the following subjects: antinocicepção, veneno de crotalus durissus terrificus, hiperalgesia, veneno de bothrops asper and veneno de serpentes crotalus durissus terrificus. (Source: Lattes Curriculum)

News published in Agência FAPESP Newsletter about the researcher
Novel formulation permits use of toxin extracted from rattlesnake venom to treat chronic pain 
Articles published in other media outlets (84 total):
More itemsLess items
UOL: Nova formulação permite usar toxina do veneno da cascavel para tratar dor (25/Apr/2020)
Revista Pará: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Apr/2020)
Central das Notícias: Toxina de veneno de cascavel consegue tratar dor crônica (23/Apr/2020)
Fatos do Iguaçu online: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Apr/2020)
Espaço Ecológico no Ar: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Apr/2020)
LabNetwork: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (23/Apr/2020)
Planeta online: Toxina de veneno de cascavel consegue tratar dor crônica (23/Apr/2020)
Blog A Crítica: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Apr/2020)
Diário da Região (São José do Rio Preto, SP) online: Nova formulação permite usar toxina do veneno de cascavel para tratar dor crônica (22/Apr/2020)
Portal da Enfermagem: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Apr/2020)
JC Notícias (São Paulo, SP): Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Apr/2020)
Atemporal: Nova formulação permite usar toxina do veneno da cascavel para tratar dor crônica (22/Apr/2020)
Agrosoft: NOVA FORMULAÇÃO PERMITE USAR TOXINA DO VENENO DA CASCAVEL PARA TRATAR DOR CRÔNICA (22/Apr/2020)
Innovaspain (Espanha): Veneno de serpiente de cascabel para combatir el dolor crónico (11/Mar/2020)
News Break (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (11/Mar/2020)
Pregon Agropecuario (Argentina): Una innovación hace posible aplicar el veneno de la serpiente de cascabel para tratar el dolor crónico (10/Mar/2020)
NCYT Amazings (Espanha): Una innovación hace posible aplicar el veneno de la serpiente de cascabel para tratar el dolor crónico (09/Mar/2020)
Catalunya Vanguardista (Espanha): Veneno de serpiente cascabel para tratar el dolor crónico (09/Mar/2020)
Herencia Genetica y Enfermedad (Argentina): Nueva formulación de Crotoxina para tratar el dolor crónico (24/Feb/2020)
AuroBlog: We Just Got Closer to Producing Painkillers From Rattlesnake Venom (24/Feb/2020)
International Business Times (Singapura): Snakes or life savers? New painkillers from Rattlesnake venom may provide relief to millions (23/Feb/2020)
ScienceAlert (Austrália): We Just Got Closer to Producing Painkillers From Rattlesnake Venom (22/Feb/2020)
Daniel Aleart (Argentina): Nueva formulación de Crotoxina para tratar el dolor crónico (19/Feb/2020)
Buffalo X Press: Brazilian Researchers Prove Crotoxin’s Therapeutic Effects Can Cure Chronic Pain (19/Feb/2020)
UGPressa (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Feb/2020)
SerTox (Argentina): Logran mejor efecto analgésico de la crotoxina al encapsularla en sílice nanoestructurada (18/Feb/2020)
Polit (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Feb/2020)
SerTox (Argentina): Better analgesic effect of crotoxin by encapsulating it in nanostructured silica, study (18/Feb/2020)
Newstes (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Feb/2020)
Science Bulletin: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (18/Feb/2020)
Polit News (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Feb/2020)
Vechnayamolodost (Rússia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (18/Feb/2020)
Technologie Média: Un nouvel analgésique venant du serpent à sonnette (17/Feb/2020)
Bioquick News (EUA): Novel Formulation Permits Use of Toxin from Rattlesnake Venom to Treat Chronic Pain (17/Feb/2020)
FarsNews Agency (Irã): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Feb/2020)
IntraMed (Argentina): Estudio en animales con veneno de serpiente de cascabel | Nueva formulación de Crotoxina para tratar el dolor crónico (17/Feb/2020)
Phys.Org (Reino Unido): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (17/Feb/2020)
European Pharmaceutical Review: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Feb/2020)
PressBoltNews (Índia): Health and medical Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Feb/2020)
Small Tech News: Rattlesnake venom complex or can become a new effective painkiller (17/Feb/2020)
Archyworldys: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (17/Feb/2020)
RCTopNews: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (16/Feb/2020)
News Medical (Austrália): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (16/Feb/2020)
Caiyisou (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
SOHU.com (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
System Daquan (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Niuzhan (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
The WB Mirror: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
cnBeta (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
QQ.com (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Obor News: Using Toxin From Rattlesnake Venom To Treat Chronic Pain (15/Feb/2020)
Xoer (Austrália): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Vijayawada Now (Índia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Tech Sina (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Kejik.com (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
KE jūn I zhāiyào: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Trap Town (Índia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Blog WONGCW (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
FBI Reform (EUA): Eurasia Review: Using Toxin From Rattlesnake Venom To Treat Chronic Pain (15/Feb/2020)
Zaker (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Bizsiziz: Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Lab Manager (Canadá): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Xiang Fang News (China): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Bio1000 (China): 新的配方允许使用响尾蛇毒液中的毒素治疗慢性疼痛 (15/Feb/2020)
Alien Gossip (Índia): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
HEA - Health Essence of Asia Group (Taiwan): Novel formulation allows use of toxin from rattlesnake venom to control neuropathic pain (15/Feb/2020)
Medindia (Índia): Toxin from Rattlesnake Venom to Treat Chronic Pain (15/Feb/2020)
WNDU 16 (EUA): Toxin From Rattlesnake Venom Formulated to Treat Chronic Pain (15/Feb/2020)
Science Codex: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Tech Deeps: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Health Medicine Network (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
RCTopNews: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Long Room (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
SciTech Daily (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
7thSpace: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Bioengineer (Reino Unido): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
HNewspaper: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Nanotechnology Now (EUA): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Scienmag Science Magazine (Reino Unido): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Scienstack: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Daily Tend (Paquistão): Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
Pharma Jobs: Novel formulation permits use of toxin from rattlesnake venom to treat chronic pain (14/Feb/2020)
New Atlas (Austrália): Rattlesnake venom compound points to promising new painkiller (14/Feb/2020)
Eurasia Review (Espanha): Using Toxin From Rattlesnake Venom To Treat Chronic Pain (14/Feb/2020)
Research grants
Scholarships in Brazil
Scholarships abroad
FAPESP support in numbers * Updated September 19, 2020
Total / Available in English
Most frequent collaborators in research granted by FAPESP
Contact researcher

Use this Research Supported by FAPESP (BV/FAPESP) channel only to send messages referring to FAPESP-funded scientific projects.


 

 

 

 

Keywords used by the researcher
Scientific publications resulting from Research Grants and Scholarships under the grantee's responsibility (8)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

Publications8
Citations36
Cit./Article4.5
Data from Web of Science

TEIXEIRA, N. B.; SANT'ANNA, M. B.; GIARDINI, A. C.; ARAUJO, L. P.; FONSECA, L. A.; BASSO, A. S.; CURY, Y.; PICOLO, G.. Crotoxin down-modulates pro-inflammatory cells and alleviates pain on the MOG(35-55)-induced experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis. BRAIN BEHAVIOR AND IMMUNITY, v. 84, p. 253-268, . Web of Science Citations: 0. (11/17974-2, 10/12903-7, 13/07467-1)

KIMURA, LOUISE FAGGIONATO; SANT'ANNA, MORENA BRAZIL; ZAMBELLI, VANESSA OLZON; GIARDINI, ALINE CAROLINA; SILVA JARED, SIMONE GONCALVES; ANTONIAZZI, MARTA MARIA; DE MOURA MATTARAIA, VANIA GOMES; PAGANO, ROSANA LIMA; PICOLO, GISELE. Early exposure to environmental enrichment protects male rats against neuropathic pain development after nerve injury. Experimental Neurology, v. 332, . Web of Science Citations: 0. (13/07467-1, 08/57898-0, 13/20795-8)

MACHADO, F. C.; ZAMBELLI, V. O.; FERNANDES, A. C. O.; HEIMANN, A. S.; CURY, Y.; PICOLO, G.. Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine. British Journal of Pharmacology, v. 171, n. 4, SI, p. 961-972, . Web of Science Citations: 19. (09/14203-5, 10/12917-8, 08/57898-0)

DIAS, RENATA GONCALVES; SAMPAIO, SANDRA COCCUZZO; SANT'ANNA, MORENA BRAZIL; CUNHA, FERNANDO QUEIROZ; GUTIERREZ, JOSE MARIA; LOMONTE, BRUNO; CURY, YARA; PICOLO, GISELE. Articular inflammation induced by an enzymatically-inactive Lys49 phospholipase A2: activation of endogenous phospholipases contributes to the pronociceptive effect. Journal of Venomous Animals and Toxins including Tropical Diseases, v. 23, n. 1, . Web of Science Citations: 1. (06/03879-0)

ZAMBELLI, VANESSA O.; PICOLO, GISELE; FERNANDES, CARLOS A. H.; FONTES, MARCOS R. M.; CURY, YARA. Secreted Phospholipases A(2) from Animal Venoms in Pain and Analgesia. TOXINS, v. 9, n. 12, . Web of Science Citations: 10. (11/17974-2, 13/07467-1, 15/01254-1)

SANT'ANNA, MORENA BRAZIL; RIBEIRO LOPES, FLAVIA SOUZA; KIMURA, LOUISE FAGGIONATO; GIARDINI, ALINE CAROLINA; SANT'ANNA, OSVALDO AUGUSTO; PICOLO, GISELE. Crotoxin Conjugated to SBA-15 Nanostructured Mesoporous Silica Induces Long-Last Analgesic Effect in the Neuropathic Pain Model in Mice. TOXINS, v. 11, n. 12, . Web of Science Citations: 1. (15/01254-1, 08/57898-0, 17/17844-8, 14/19397-0)

ZULIM DE CARVALHO, ANA EDUARDA; GIANNOTTI, KARINA; LEIGUEZ JUNIOR, ELBIO; MATSUBARA, MARCIO; DOS SANTOS, MARIA CRISTINA; FORTES-DIAS, CONSUELO LATORRE; TEIXEIRA, CATARINA. Crotalus durissus ruruima Snake Venom and a Phospholipase A(2) Isolated from This Venom Elicit Macrophages to Form Lipid Droplets and Synthesize Inflammatory Lipid Mediators. JOURNAL OF IMMUNOLOGY RESEARCH, v. 2019, . Web of Science Citations: 0. (15/24701-3, 14/18549-1, 18/05637-0, 15/50040-4)

KIMURA, LOUISE FAGGIONATO; DE MOURA MATTARAIA, VANIA GOMES; PICOLO, GISELE. Distinct environmental enrichment protocols reduce anxiety but differentially modulate pain sensitivity in rats. Behavioural Brain Research, v. 364, p. 442-446, . Web of Science Citations: 5. (11/17974-2, 08/57898-0, 13/20795-8)

Patent applications

ANALGESIC COMPOUNDS CA2685720 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Laboratório Biosintética Ltda; Yara Cury. Yara Cury; Gisele Picolo; Katsuhiro Konno - April 2008, 30

ANALGESIC COMPOUNDS CN200880023231 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Laboratório Biosintética Ltda; Yara Cury. Yara Cury; Gisele Picolo; Katsuhiro Konno - April 2008, 30

ANALGESIC COMPOUNDS EP20080733530 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Laboratório Biosintética Ltda; Yara Cury. Yara Cury; Gisele Picolo; Katsuhiro Konno - April 2008, 30

ANALGESIC COMPOUNDS PCT/BR2008/000127 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Laboratório Biosintética Ltda; Yara Cury. Yara Cury; Gisele Picolo; Katsuhiro Konno - April 2008, 30

PROCESSO DE SINTESE E COMPOSIÇÕES FARMACÊUTICAS DE PEPTÍDEOS E ANÁLOGOS, DERIVADOS DO VENENO DE SERPENTES POR EXEMPLO, DO GÊNERO CROTALUS, COM ATIVIDADE ANALGÉSICA, USOS E PRODUTOS ASSOCIADOS PI0401702-1 - Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Laboratório Biosintética Ltda; Yara Cury. Yara Cury; Gisele Picolo; Katsuhiro Konno - May 2004, 06

Please report errors in researcher information by writing to: cdi@fapesp.br.
X

Report errors in this page


Error details: